Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PCNA | P12004 | 14/20 | 1.00 |
| ▸ | LIG1 | P18858 | 1/20 | 1.00 |
| ▸ | THRB | P10828 | 5/20 | 0.51 |
| ▸ | THRA | P10827 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | GABRP | O00591 | 1/20 | 0.51 |
| ▸ | GABRD | O14764 | 1/20 | 0.51 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.51 |
| ▸ | F2 | P00734 | 1/20 | 0.51 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.51 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.51 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.51 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.51 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.51 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.51 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14485173 | 1.00 | PCNA (1.00) | PCNALIG1THRBTHRALMNA | |
| SCHEMBL14485381 | 1.00 | PCNA (1.00) | PCNALIG1THRBTHRALMNA | |
| SCHEMBL22382798 | 0.91 | PCNA (0.83) | PCNALIG1THRBTHRALMNA | |
| SCHEMBL14484721 | 0.89 | PCNA (0.80) | PCNALIG1THRBTHRALMNA | |
| SCHEMBL14484719 | 0.89 | PCNA (0.80) | PCNALIG1THRBTHRALMNA | |
| SCHEMBL16124416 | 0.89 | PCNA (0.80) | PCNALIG1THRBTHRALMNA | |
| SCHEMBL16124414 | 0.87 | PCNA (0.78) | PCNALIG1THRBTHRALMNA | |
| SCHEMBL16124477 | 0.87 | PCNA (0.78) | PCNALIG1THRBTHRALMNA | |
| SCHEMBL16124413 | 0.87 | PCNA (0.78) | PCNALIG1THRBTHRALMNA | |
| SCHEMBL16124462 | 0.86 | PCNA (0.76) | PCNALIG1THRBTHRALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11400130-B2 | Inhibitors for proliferating cell nuclear antigen and uses | PURDUE RESEARCH FOUNDATION (US) | 2022-08-02 | — | — | US | disclosed |
| US-20220160813-A1 | INHIBITORS FOR PROLIFERATING CELL NUCLEAR ANTIGEN AND USES | PURDUE RESEARCH FOUNDATION (US) | 2022-05-26 | — | — | US | disclosed |
| US-10758588-B2 | Inhibitors for proliferating cell nuclear antigen and uses | PURDUE RESEARCH FOUNDATION (US) | 2020-09-01 | — | — | US | disclosed |
| US-20180360905-A1 | INHIBITORS FOR PROLIFERATING CELL NUCLEAR ANTIGEN AND USES | PURDUE RESEARCH FOUNDATION (US) | 2018-12-20 | — | — | US | disclosed |
| WO-2017100154-A1 | INHIBITORS FOR PROLIFERATING CELL NUCLEAR ANTIGEN AND USES | PURDUE RESEARCH FOUNDATION (US) | 2017-06-15 | — | — | WO | disclosed |
| US-20140288077-A1 | SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2014-09-25 | — | — | US | disclosed |
| US-20140288077-A1 | SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2014-09-25 | — | — | US | disclosed |
| US-20140288077-A1 | SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2014-09-25 | — | — | US | disclosed |
| WO-2013006734-A1 | SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 2013-01-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180360905-A1 | INHIBITORS FOR PROLIFERATING CELL NUCLEAR ANTIGEN AND USES | MKI67, PCNA, PCLAF | PCNA 2/4885LIG1 1241/4885THRB 3996/4885 |
| US-11400130-B2 | Inhibitors for proliferating cell nuclear antigen and uses | MKI67, PCNA, PCLAF | PCNA 2/4885LIG1 1241/4885THRB 3996/4885 |
| US-20220160813-A1 | INHIBITORS FOR PROLIFERATING CELL NUCLEAR ANTIGEN AND USES | MKI67, PCNA, PCLAF | PCNA 2/4885LIG1 1241/4885THRB 3996/4885 |
| US-20140288077-A1 | SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY | MKI67, PCNA, PCLAF | PCNA 2/4885LIG1 1098/4885THRB 2853/4885 |
| US-10758588-B2 | Inhibitors for proliferating cell nuclear antigen and uses | MKI67, PCNA, PCLAF | PCNA 2/4885LIG1 1241/4885THRB 3996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.